Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Beroni Group's Days Payable or its related term are showing as below:
XNEC:BTG's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 90.22 * Ranked among companies with meaningful Days Payable only.
Beroni Group's Days Payable
increased
from Jun. 2023 (539.32) to Jun. 2024 (1,331.57).
It may suggest that Beroni Groupdelayed paying its suppliers.
Beroni Group Days Payable Related Terms
Beroni Group Days Payable Historical Data
* Premium members only.
The historical data trend for Beroni Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XNEC:BTG vs PNXP, CRYM, GCAN: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Beroni Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beroni Group Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beroni Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Beroni Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Beroni Group's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beroni Group (XNEC:BTG) has a Days Payable of 1,331.57 as of Jun. 2024. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Beroni Group and its competitors.
Is Beroni Group's Days Payable too high?
Beroni Group's current Days Payable is 1,331.57. The Drug Manufacturers industry median Days Payable is 90.22. Beroni Group's value of 1,331.57 is 1375.9% above this industry median. Overall, Beroni Group has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Beroni Group's Days Payable compare to PNXP and CRYM?
Beroni Group's Days Payable of 1,331.57 can be compared against companies in the Drug Manufacturers industry. The industry median Days Payable is 90.22. Beroni Group's value of 1,331.57 is 1375.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.22, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beroni Group's current Days Payable of 1,331.57 is 1375.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Beroni Group and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beroni Group's current Days Payable is 1,331.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beroni Group stock overvalued right now?
Beroni Group (XNEC:BTG) has a current Days Payable of 1,331.57. The current Days Payable is 1,331.57 and 1375.9% above the Drug Manufacturers industry median of 90.22. Beroni Group's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Beroni Group (XNEC:BTG), the current Days Payable is 1,331.57 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Beroni Group Ltd is an Australia based company engaged in the sales of smoking control product (NicoBloc), air purifier, water filter, healthcare products and supplements, cell therapies, stem-cell based cosmetics and viral diagnostic kits and also investing in the research and development of oncology drugs and therapies. It has organized its business into four core business areas: cell therapies, developing new anticancer drugs, an e-commerce platform for pharmaceutical and healthcare products, and detection & diagnosis of infectious diseases. Geographically, the company operates in China.
4GF Score
Get the complete analysis for XNEC:BTG
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XNEC:BTG has been successfully added to your 
